8 results
DEFA14A
BLPH
Bellerophon Therapeutics, Inc.
12 Feb 24
Additional proxy soliciting materials
12:39pm
for wind-down administration services and retainage, (iii) approximately $200,000 payable for legal fees, (iv) approximately $150,000 payable for wages
8-K
BLPH
Bellerophon Therapeutics, Inc.
21 Nov 23
Departure of Directors or Certain Officers
12:00am
businesses and has served, and continues to serve, in the capacities of officer and director for numerous firms in their wind-down phases
8-K
EX-2.1
muqydr1pl4 kn
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:45am
10-K
EX-2.1
i56 e658ob2izy
31 Mar 15
Annual report
12:00am
- Prev
- 1
- Next